Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GUMM - Eliminate the Common Cold -- Ignore unavailable to you. Want to Upgrade?

To: Mark Marcellus who wrote (3434)	12/7/2000 11:13:56 PM
From: Mike M	Respond to of 5582

Just because I don't respond to every post from Dan or anybody else doesn't mean I agree with them. In fact, I didn't disagree with your challenge of his comments except that you tried to include GUMM in a group in which they don't belong any more than with PFE. I chose not to respond to either comment. There is little point in trying to compare the channel used by GUMM with that of Nyquil at this stage in GUMM's development. I am amazed that you even find this worthy of an attempt to defame. If it is important to you, I will gladly stipulate that GUMM has much to learn about distribution. On the other hand, for a tiny company with almost no resources, they didn't do to badly getting the product on the shelves of 50,000 stores. Irrespective of what bulls or bears may demand, I don't find it necessary to hold GUMM up to the standards of J&J, PFE, or MRK quite yet. There isn't a company out there that cannot wilt under critical scrutiny. For instance: why don't you beat up on GE for a while for...failing to clean up their PCB mess? Oh, and I found Arm&Hammer's dental gum display in disarray at my Kroger's yesterday. Who do we hold accountable?